Eyemaxx Real Estate AG

  • WKN: A0V9L9
  • ISIN: DE000A0V9L94
  • Land: Deutschland

Nachricht vom 11.01.2019 | 10:50

EYEMAXX Real Estate AG: EYEMAXX plans dual listing at the Vienna Stock Exchange

DGAP-News: EYEMAXX Real Estate AG / Key word(s): Miscellaneous

11.01.2019 / 10:50
The issuer is solely responsible for the content of this announcement.

EYEMAXX plans dual listing at the Vienna Stock Exchange

Aschaffenburg, 11 January 2019 - EYEMAXX Real Estate AG (General Standard; ISIN DE000A0V9L94; "EYEMAXX") plans a dual listing of its shares at the Vienna Stock Exchange in the new market segment "direct market plus", which will start on 21 January 2019. This means that EYEMAXX will have an even broader positioning on the capital market and increase its visibility for Austrian investors.

The shares of EYEMAXX Real Estate AG have been listed in Germany in the General Standard since 2011. In addition, bonds of the company are listed on the stock exchange in Germany.

Dr. Michael Müller, CEO der EYEMAXX Real Estate AG, explains: "The fact that our shares will now also be tradeable at the Vienna Stock Exchange makes us more interesting for a broader group of investors. In this way we also increase the visibility on the Austrian capital market, which is likely to have a positive impact on our ongoing profitable growth. Since we meet already strict transparency obligations as a result of our listing in the General Standard in Germany, the dual listing in Vienna will not involve any significant additional efforts."

Mag. Maximilian Pasquali, LL.M., Deputy CEO EYEMAXX Group, comments: "Austria is, for instance in the field of residential properties, in addition to Germany, among our core markets in project development. Although our registered office is in Germany, we coordinate the operational activities from Leopoldsdorf near Vienna. This is another reason why a listing in Austria is obvious for us, as a supplement to our listing in Germany."

About EYEMAXX Real Estate AG

EYEMAXX Real Estate AG is a real estate company with a long-standing successful track record, focussing on residential properties in Germany and Austria. In addition, EYEMAXX also realises nursing homes in Germany and commercial properties in central Europe. In the company's recent past its corporate strategy has also included developing urban districts in Germany.

EYEMAXX' business activities take a dual-pronged approach. These include high-margin projects and also the continued expansion of its stocks of let commercial properties, which generate ongoing rental income and thus constant cash flows. In so doing, EYEMAXX uses the expertise offered by its experienced management team together with a strong team of real estate professionals, and also a well-established and broad network which opens up additional access to attractive properties and projects. The current project pipeline has thus been expanded to around EUR 975 million.

Shares of EYEMAXX Real Estate AG are listed in the General Standard of the Frankfurt Stock Exchange. The company has also issued several bonds, which are also listed on the stock exchange.

You can find more information at: www.eyemaxx.com


Investor Relations / Financial press
Axel Mühlhaus, Peggy Kropmanns
edicto GmbH
Tel.: +49 69 905505-52
E-mail: eyemaxx@edicto.de

11.01.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

show this


HELMA Eigenheimbau: Klarer Kauf

Die HELMA Eigenheimbau hat mit dem Zugang weiterer Ferienimmobilienprojekte das potenzielle Umsatzvolumen um 150 Mio. € gesteigert. Ohnehin verfügt die Gesellschaft über einen umfangreichen Grundstücksbestand für das Bauträgergeschäft, womit in den kommenden Geschäftsjahren Umsätze in Höhe von über 1,4 Mrd. € realisiert werden könnten. Damit dürften unsere Schätzungen, in denen wir ein nachhaltiges Überschreiten der Umsatzmarke von 300 Mio. € annehmen, gut unterfüttert sein. Bei einem Kursziel von 65,00 € ist die HELMA-Aktie ein klarer Kauf.

News im Fokus

Fresenius Medical Care erreicht Ziele für Geschäftsjahr 2019 und bestätigt Ausblick 2020 auf nachhaltiges profitables Wachstum

19. Februar 2020, 20:58

Aktuelle Research-Studie

Eyemaxx Real Estate AG

Original-Research: Eyemaxx Real Estate AG (von GBC AG): Kaufen

20. Februar 2020